Genomic instability in TP53-mutated breast cancer cells treated with etoposide and doxorubicin.

被引：0
|
作者：
De Vos, ML [1 ]
Weber, BL [1 ]
机构：
[1] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2003年 / 73卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
330
引用
收藏
页码：226 / 226
页数：1
相关论文
共 50 条
  • [21] Curcumin Enhances Ibrutinib Induced Killing Effect Against TP53-Mutated Chronic Lymphocytic Leukemia Cells in Vitro
    Zhang, Yunxia
    Lei, Haohao
    Wei, Xiaolei
    Wei, Yongqiang
    Feng, Ru
    Guo, Xutao
    BLOOD, 2023, 142
  • [22] CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer
    Liu, Yanfeng
    Wang, Fan
    Yan, Guoquan
    Tong, Yu
    Guo, Wenyun
    Li, Songling
    Qian, Yifei
    Li, Qianyu
    Shu, Yu
    Zhang, Lei
    Zhang, Yonglong
    Xia, Qiang
    CANCER LETTERS, 2024, 595
  • [23] TP53 ABNORMALITIES AND GENETIC INSTABILITY IN BREAST-CANCER
    EYFJORD, JE
    THORLACIUS, S
    VALGARDSDOTTIR, R
    GRETARSDOTTIR, S
    STEINARSDOTTIR, M
    ANAMTHAWATJONSSON, K
    ACTA ONCOLOGICA, 1995, 34 (05) : 663 - 667
  • [24] Curcumin enhances ibrutinib induced killing effect against TP53-mutated chronic lymphocytic leukemia cells in vitro
    Zhang, Yunxia
    Guo, Xutao
    Feng, Ru
    Wei, Xiaolei
    Wei, Yongqiang
    Lei, Haohao
    LEUKEMIA & LYMPHOMA, 2023, 64 : S118 - S119
  • [25] Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer
    Inoue, Akira
    Robinson, Frederick S.
    Minelli, Rosalba
    Tomihara, Hideo
    Rizi, Bahar Salimian
    Rose, Johnathon L.
    Kodama, Takahiro
    Srinivasan, Sanjana
    Harris, Angela L.
    Zuniga, Andy M.
    Mullinax, Robert A.
    Ma, Xiaoyan
    Seth, Sahil
    Daniele, Joseph R.
    Peoples, Michael D.
    Loponte, Sara
    Akdemir, Kadir C.
    Khor, Tin Oo
    Feng, Ningping
    Roszik, Jason
    Sobieski, Mary M.
    Brunell, David
    Stephan, Clifford
    Giuliani, Virginia
    Deem, Angela K.
    Shingu, Takashi
    Deribe, Yonathan Lissanu
    Menter, David G.
    Heffernan, Timothy P.
    Viale, Andrea
    Bristow, Christopher A.
    Kopetz, Scott
    Draetta, Giulio F.
    Genovese, Giannicola
    Carugo, Alessandro
    GASTROENTEROLOGY, 2021, 161 (01) : 196 - 210
  • [26] Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.
    Tang, Lichen
    He, Min
    Wu, Jiong
    Wang, Zhonghua
    Liu, Guangyu
    Yu, Keda
    Geng, Cuizhi
    Fan, Zhimin
    Ling, Rui
    Qiao, Guangdong
    Cai, Li
    Luo, Ting
    Jin, Feng
    Wang, Haibo
    Zhang, Anqin
    Zhang, Hongwei
    Zeng, Xiaohua
    Wang, Xiaojia
    Jiang, Ming
    Shao Zhimin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers
    Gyorffy, Balazs
    Bottai, Giulia
    Lehmann-Che, Jacqueline
    Keri, Gyorgy
    Orfi, Laszlo
    Iwamoto, Takayuki
    Desmedt, Christine
    Bianchini, Giampaolo
    Turner, Nicholas C.
    de The, Hugues
    Andre, Fabrice
    Sotiriou, Christos
    Hortobagyi, Gabriel N.
    Di Leo, Angelo
    Pusztai, Lajos
    Santarpia, Libero
    MOLECULAR ONCOLOGY, 2014, 8 (03) : 508 - 519
  • [28] Growth of human breast cancer cells at acidic pH enhances their resistance to paclitaxel and doxorubicin.
    Cheng, H
    Cobos, E
    Jackson, M
    Martinez, GM
    Martinez-Zaguilan, R
    BLOOD, 2000, 96 (11) : 100A - 100A
  • [29] TP53-Mutated Acute Myeloid Leukemia Patients Treated with Intensive Therapies Have Superior Outcomes: A Single Institution, Retrospective Study
    Sumransub, Nuttavut
    Steinwand, Gabriel K.
    Lee, Yoonkyu
    Cao, Qing
    Allred, Jeremy R.
    Ramesh, Vidhyalakshmi
    Myers, Chad L.
    Sachs, Zohar
    BLOOD, 2023, 142
  • [30] Exosomal p38 Mitogen-activated Protein Kinase Promotes Tumour Repopulation in TP53-mutated Bile Duct Cancer Cells
    Osawa, Mami
    Matsuda, Yasunobu
    Sakata, Jun
    Wakai, Toshifumi
    ANTICANCER RESEARCH, 2022, 42 (02) : 745 - 757
12345